| Detailed information |
|---|
| CancerLivER ID | 2566 |
| Biomarker | Matrixmetalloproteinase14 or MMP14, MT-MMP1,osteonectin/SPARC |
| Biomarker Name/Symbol (given in Publication) | Matrixmetalloproteinase14 or MMP14, MT-MMP1,osteonectin/SPARC |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potential diagnotic marker for HCC; but not validated on independent daatset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in all three tested HCC samples. |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 11813304 |
| Type of Biomarker | Diagnostic |
| Pathway | regulatory pathways. |
| Cohort | Paired Tumor and corresponding nontumor liver tissues were obtained from 3 HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCV-HCC vs Normal |
| Year of Publication | 2002 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |